Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats.
It is generally believed that the cholinergic system plays an important role in normal cognitive functioning. Botulinum toxin is the most potent toxin of the peripheral cholinergic system and today it is used in the treatment of a variety of neurological disorders. However, it is surprising that its effect on cognitive processes has been investigated in only two publications. Short-term effects of the central application of botulinum toxin (BTX) type B have been associated with cognitive impairment in animals, while results with type A are ambiguous. In the present study, we have investigated the duration of memory impairment after an intracerebroventricular administration of BTX-A in rats. Two experiments were performed, lasting 12 and 5 months, respectively. In both experiments, the same dose of BTX-A was applied (2 U/kg) and the Morris water maze test was used in the assessment of memory performance. Results show that a single icv injection of a small dose of BTX-A significantly impairs the water maze performance. In both experiments, impairment was apparently of a slow onset and long lasting (up to 12 months). The length and pattern of attenuation suggest development of dementia-like deficits. In addition to providing a potentially new experimental model of memory impairment, these results question the idea of an intracranial application of BTX in the treatment of CNS disorders.
Lacković
Zdravko
Z
Laboratory of Molecular Neuropharmacology, Department of Pharmacology and Croatian Institute of Brain Research, School of Medicine, University of Zagreb, Zagreb, Croatia. lac@mef.hr
Rebić
Veseljka
V
Riederer
Peter F
PF
D000818:Animals; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000494:pharmacology*; D007276:Injections, Intraventricular; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D008569:Memory Disorders / Q000139:chemically induced*; D009043:Motor Activity / Q000187:drug effects; D009483:Neuropsychological Tests; D009498:Neurotoxins / Q000008:administration & dosage / Q000494:pharmacology*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
D009498:Neurotoxins; D019274:Botulinum Toxins, Type A
Physiol Behav. 1993 Dec;54(6):1227-33
7507594
J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):951-7
15201348
J Neurosci Res. 2002 Nov 1;70(3):519-27
12391613
Curr Opin Neurobiol. 1995 Apr;5(2):184-90
7620306
Toxicon. 2002 Jul;40(7):923-8
12076646
J Neuropathol Exp Neurol. 2006 Nov;65(11):1074-81
17086104
Brain Res. 2002 Sep 20;950(1-2):245-53
12231250
J Neurochem. 1988 Jun;50(6):1808-16
2897427
J Neurochem. 1999 May;72(5):1991-8
10217276
J Alzheimers Dis. 2006;9(3 Suppl):35-44
16914843
Behav Pharmacol. 2004 May;15(3):233-40
15187581
Behav Neurosci. 1986 Feb;100(1):23-32
3954876
Neuroreport. 1992 Nov;3(11):1005-8
1482757
Q J Exp Psychol B. 1986 Nov;38(4):365-95
3809580
Life Sci. 1967 Feb 1;6(3):281-91
6071872
Eur J Neurosci. 1995 Feb 1;7(2):329-43
7757267
Eur J Pharmacol. 1997 Mar 12;322(1):11-9
9088864
Neurobiol Learn Mem. 2003 Nov;80(3):194-210
14521863
Neurosci Biobehav Rev. 1998;22(1):99-120
9491942
Eur J Neurosci. 2007 Mar;25(5):1581-8
17355252
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7965-70
12802017
Traffic. 2007 Feb;8(2):142-53
17241445
J Comp Physiol Psychol. 1978 Dec;92(6):1119-27
755058
Lijec Vjesn. 2007 Dec;129(12):407-14
18383744
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593
16437532
Brain Res Brain Res Rev. 1997 Feb;23(1-2):28-46
9063585
Brain Res Brain Res Rev. 2001 Aug;36(1):60-90
11516773
Neurobiol Learn Mem. 2003 Nov;80(3):245-56
14521867
Pharmacol Biochem Behav. 1996 Sep;55(1):107-15
8870045
J Pharmacol Exp Ther. 1989 Feb;248(2):825-35
2918482
Neuroscience. 1994 Nov;63(1):95-122
7898665
J Physiol Paris. 2002 Jan-Mar;96(1-2):105-13
11755789
Brain Res Brain Res Rev. 2003 Mar;41(2-3):268-87
12663083
Neuroscience. 2007 May 25;146(3):875-89
17418958
J Neural Transm (Vienna). 2005 Feb;112(2):215-9
15657640
Physiol Behav. 1994 Jul;56(1):111-4
8084888
Life Sci. 1996;58(1):47-54
8628110
Brain Res. 1981 Jul 27;217(1):41-58
7260619
J Neurosci. 2008 Apr 2;28(14):3689-96
18385327
Annu Rev Psychol. 1997;48:649-84
9046571
Neurotox Res. 2006 Apr;9(2-3):197-203
16785118
Lancet. 1976 Dec 25;2(8000):1403
63862
Science. 1976 Sep 24;193(4259):1256-8
785600
Behav Neural Biol. 1993 Mar;59(2):150-7
8476382